Clinical trial

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

NCT00433121 · Sykehuset Innlandet HF, Other · Completed

Key facts

NCT number NCT00433121
Title Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
Official title Discontinuation of Antipsychotics and Antidepressants Among Patients With Dementia and BPSD Living in Nursing Homes - an Open Study.
Lead sponsor Sykehuset Innlandet HF, Other
Collaborators Demensforbundet, Norway
Status Completed
Phase Phase 4
Study type Interventional
Conditions Dementia
Intervention type Drug
Interventions Risperidone, Olanzapine, Haloperidole, Quetiapin, Escitalopram, Citalopram, Sertralin
Enrollment 24
Start date Sep 1, 2006
Completion Aug 1, 2007
First posted Feb 9, 2007
Last update posted Aug 24, 2007
Countries Norway

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies